BLFS Q2 2023 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$40M-2.5% YoY

Gross Profit

$12M29.9% margin

Operating Income

-$15M-38.7% margin

Net Income

-$10M-25.8% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$433M

Total Liabilities

$81M

Stockholders' Equity

-$271M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$41M	-2.5%
Gross Profit	$12M	$14M	-17.6%
Operating Income	-$15M	-$9M	-75.3%
Net Income	-$10M	-$73M	+85.9%

Revenue Segments

Product

$33M47%

Product, Cell Processing

$19M27%

Product, Freezer and Thaw

$14M20%

Service

$4M6%